Table 2 Frequency and the number of fusion types of PLEKHA1-TACC2 identified in different types of cancers.
Cancer type | Total samples | Positive samples | Frequency |
|---|---|---|---|
ESCC | 404 | 66 | 16.3% |
HNSCC | 402 | 58 | 14.4% |
CRC | 164 | 22 | 13.4% |
HCC | 158 | 22 | 13.9% |
LC | 79 | 7 | 8.9% |
GC | 80 | 12 | 15% |
BC | 132 | 0 | 0% |